普萘洛尔联合硝酸异山梨酯对冠心病心绞痛患者Obestatin、tPAI-1、Fractalkine水平的影响

Abstract
Figure/Table
References (21)
Related Citation (15)

Download: PDF (479 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Propranolol combined with Isosorbide Nitrate on patients with coronary heart disease and angina pectoris, and the effect on levels of Obestatin, tissue-plasminogen activator inhibitor-1 (tPAI-1) and irregular chemokines (Fractalkine). Methods A total of 126 patients with coronary heart disease and angina pectoris who were treated in Guang’an People’s Hospital, Sichuan Province from April 2018 to April 2019 were selected and divided into control group and treatment group according to the random number table method, with 63 cases in each group. The control group was treated with Isosorbide Nitrate. The treatment group was treated with Propranolol combined with Isosorbide Nitrate. Both groups received continuous treatment for 14 days. The incidence of angina pectoris was observed. The cardiac functions of the two groups were examined, the serum and other relevant indicators levels were detected, and the therapeutic effect of the two groups was compared. Results After treatment, the number and duration of angina pectoris attacks in the treatment group were lower than those in the control group, and the differences were statistically significant (all P ＜ 0.05). The level of left ventricular posterior wall thickness in the treatment group was lower than that in the control group, the levels of left ventricular ejection fraction and cardiac output in the treatment group were higher than those in the control group, and the differences were statistically significant (all P ＜ 0.05). The level of serum glutathione peroxidase in the treatment group was higher than that in the control group, while lipid peroxide, malondialdehyde, Obestatin, tPAI-1, Fractalkine levels were all lower than those in the control group, and the differences were statistically significant (all P ＜ 0.05). The total effective rate of the treatment group was higher than that of the control group, the difference was statistically significant (P ＜ 0.05). Conclusion Patients with coronary heart disease and angina pectoris treated with Pronalolol combined with Isosorbide Nitrate can improve the occurrence of angina pectoris, improve the cardiac function and antioxidant capacity, and improve the levels of serum Obestatin, tPAI-1 and Fractalkine.

Key words： Propranolol Isosorbide Nitrate Coronary heart disease Angina pectoris

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DENG Jing1 WANG Chunlian1▲ WEN Junjie2 WU Bin1

Cite this article:

DENG Jing1 WANG Chunlian1▲ WEN Junjie2 WU Bin1. Effects of Propranolol combined with Isosorbide Nitrate on the levels of Obestatin, tPAI-1 and Fractalkine in patients with coronary heart disease and angina pectoris[J]. 中国医药导报, 2020, 17(32): 56-59.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2020/V17/I32/56

[1] 吴舒窈，刘艳，宋倩，等.冠心病发病及预后的影响因素研究[J].中国全科医学，2018，21（29）：3562-3570.
[2] 李晨怡，陈佳，施向凡，等.不同性别血尿酸水平与冠心病的相关性[J].中国医学科学院学报，2018，40（3）：338-343.
[3] 李自青，闫玉清，张年萍，等.Toll样受体信号通路与冠心病关系的生物信息学分析[J].中国全科医学，2019，22（17）：2069-2074.
[4] 姜春玲.美托洛尔联合曲美他嗪治疗冠心病心力衰竭的疗效及安全性分析[J].陕西医学杂志，2016，45（8）：1064-1065.
[5] 中华医学会心血管病学分会，中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志，2007，35（3）：195-206.
[6] 刘平平.阿司匹林肠溶片联合氯吡格雷治疗冠心病心绞痛患者的临床效果研究[J].基层医学论坛，2019，23（23）：3307-3308.
[7] 姜姝，孙淼淼，宋魏，等.参麦注射液联合长效硝酸异山梨酯对冠心病心绞痛患者血小板聚集率的影响[J].世界中医药，2019，14（8）：2092-2095.
[8] 宋云方，赵飞博.硝酸异山梨酯片联合注射用丹参多酚酸盐对冠心病患者心肌酶谱、炎性因子、血脂及血液流变学指标的影响[J].中国医院用药评价与分析，2017，17（5）：619-622.
[9] 崔秀春，尹维斌，廖中廷，等.红花黄色素氯化钠注射液联合普萘洛尔治疗冠心病心绞痛的临床研究[J].现代药物与临床，2019，34（8）：2287-2292.
[10] 宋媛，都雯，马蕾，等.银杏黄酮苷与复方丹参片对冠心病心绞痛患者心电图、心功能、血液流变学的影响对比分析[J].世界中医药，2017，12（8）：1764-1766，1770.
[11] 闫继锋，于运福，闫萌，等.注射用血塞通冻干粉针剂联合尼可地尔对冠心病心绞痛患者心功能及CD4+/CD8+水平的影响[J].中国免疫学杂志，2019，35（20）：2532-2538.
[12] 邱丹，王凡，赵涛，等.丹参多酚酸盐治疗冠心病心绞痛的疗效及其对血液流变学、氧化应激的影响[J].安徽医药，2018，22（1）：147-151.
[13] 张震华，谢之微.参松养心胶囊联合曲美他嗪片对冠心病心绞痛病人血清氧化应激指标的影响[J].中西医结合心脑血管病杂志，2017，15（19）：2420-2422.
[14] 王静娜，侯瑞田，金凤表，等.通心络胶囊对2型糖尿病合并冠心病病人氧化应激的影响[J].中西医结合心脑血管病杂志，2017，15（21）：2727-2729.
[15] 荣鸽璇，李昕玲，谭弘，等.大柴胡汤加减对冠心病不稳定型绞痛的多中心、随机、双盲对照临床研究[J].世界中医药，2019，14（4）：882-886.
[16] 邱丹，王凡，赵涛，等.丹参多酚酸盐治疗冠心病心绞痛的疗效及其对血液流变学、氧化应激的影响[J].安徽医药，2018，22（1）：147-151.
[17] 章陈晨，刘凌琳，宋双双，等.通心络治疗冠心病心绞痛对氧化应激及炎性因子的影响[J].心脑血管病防治，2019， 19（4）：366-367，376.
[18] 吴正浩，陈捷.人巨细胞病毒感染对老年冠心病患者冠状动脉病变程度及Ghrelin／Obestatin的影响[J].山东医药，2016，56（44）：46-48.
[19] 张寿莉，都渝.阿托伐他汀联合氯吡格雷治疗冠心病心绞痛的临床疗效[J].实用心脑肺血管病杂志，2017，25（9）：110-113.
[20] 王永霞，朱斌.麝香保心丸联合地尔硫卓治疗老年冠心病稳定型心绞痛的临床疗效[J].成都医学院学报，2020， 15（3）：373-375.
[21] 任培乐，王领，杨盼，等.冠心病患者血清Fractalkine水平与临床检测指标相关性研究[J].海南医学院学报，2018， 24（19）：1711-1715.